Adocia vs CRISPR Therapeutics

Adocia vs CRISPR Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adocia is on 46/100 and CRISPR Therapeutics on 64/100.

Adocia logo
AdociaA clinical-stage biopharmaceutical company focused on innovative therapeutic solutions for diabetes and obesity.
Try Adocia
CRISPR Therapeutics logo
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Try CRISPR Therapeutics

Where each one leads

Adocia

Leads on none of the measures we hold for both companies.

CRISPR Therapeutics

  • our overall score: 64/100 against 46/100
  • agent readiness: 44/100 against 21/100
  • domain rating: 67/100 against 32/100

At a glance

MeasureAdociaCRISPR Therapeutics
What it isA clinical-stage biopharmaceutical company focused on innovative therapeutic solutions for diabetes and obesity.Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
CategoryBiotechnology, Pharmaceuticals, HealthcareBiotechnology, Gene Editing, Therapeutics, Pharmaceuticals
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20052013
HeadquartersLyon, FranceZug, Switzerland
StatusActiveActive

Size, funding and growth

MeasureAdociaCRISPR Therapeutics
Employees90Not published
Total fundingNot published$547M
Latest roundShareholder LoanSeries B
Valuation$1.1BNot published
LinkedIn followers12,837Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdociaCRISPR Therapeutics
StartupHub scoreOur 0-100 rating46/10064/100
Traction20/10040/100
TeamNot published70/100
Search visibility23/10013/100
Quality68/10088/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (44/100)
Domain ratingLink authority, 0-10032/10067/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdociaCRISPR Therapeutics
HostingOVHSelf Managed
CMSWordPressNot detected
FrameworksJquery, BootstrapJquery
AnalyticsGoogle Analytics 4Google Analytics 4

Adocia vs CRISPR Therapeutics: common questions

Which is better, Adocia or CRISPR Therapeutics?

On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do Adocia and CRISPR Therapeutics compare on the numbers?

CRISPR Therapeutics leads on our overall score (64/100 against 46/100), agent readiness (44/100 against 21/100), domain rating (67/100 against 32/100).

Read the full Adocia review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Adocia alternatives we track.